Literature DB >> 11273984

Preprescription genotyping: not yet ready for prime time, but getting there.

D M Roden, N J Brown.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11273984     DOI: 10.1161/01.cir.103.12.1608

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

Review 1.  Genetic polymorphisms of adrenergic receptors.

Authors:  E M Garland; I Biaggioni
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

Review 2.  Pharmacogenomics: will the promise be fulfilled?

Authors:  Russ B Altman; Heyo K Kroemer; Catherine A McCarty; Mark J Ratain; Dan Roden
Journal:  Nat Rev Genet       Date:  2010-11-30       Impact factor: 53.242

Review 3.  Personalized medicine and the genotype-phenotype dilemma.

Authors:  Dan M Roden
Journal:  J Interv Card Electrophysiol       Date:  2011-04-08       Impact factor: 1.900

Review 4.  New molecular insights into heart failure and cardiomyopathy: potential strategies and therapies.

Authors:  G A MacGowan; D M McNamara
Journal:  Ir J Med Sci       Date:  2002 Apr-Jun       Impact factor: 1.568

Review 5.  The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Authors:  G Neil Thomas; Paul Chan; Brian Tomlinson
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

6.  Gene Variant of the Bradykinin B2 Receptor Influences Pulmonary Arterial Pressures in Heart Failure Patients.

Authors:  Thomas P Olson; Robert P Frantz; Stephen T Turner; Kent R Bailey; Christina M Wood; Bruce D Johnson
Journal:  Clin Med Circ Respirat Pulm Med       Date:  2009-02-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.